Exploring the Science and Myths of Medical Cannabis CME Webinar Part 1 Survey

Question Title

* 1. Which endocannabinoid receptor has a higher density in the CNS and is responsible for the psychoactive effects of THC?

CB1

CB2

Question Title

* 2. CB1 and CB2 receptors are only found in the brain.

True

False

Question Title

* 3. ⁠⁠CBD and THC are the only phytocannabinoids that have beneficial effects.

True

False

Question Title

* 4. Should cannabis be taught in medical school/residency? (Yes or No and Why?)

Question Title

* 5. Please rate how much you agree or disagree with the following statements. (1-Strongly Disagree to 5-Strongly Agree)

	1-Strongly Disagree	2-Disagree	3-Neutral	4-Agree	5-Strongly Agree
After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products.	After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products. 1-Strongly Disagree	After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products. 2-Disagree	After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products. 3-Neutral	After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products. 4-Agree	After participating in this educational activity, I am better able to discuss the basic functions of the endocannabinoid system; identify the structural and functional components of the endocannabinoid system; describe endocannabinoid receptor mechanisms of action, locations, densities, and functions; identify the types of cannabinoids (endo- and phytocannabinoids) and how they can modulate the endocannabinoid system; define the legal status of hemp and compare hemp’s legal status to cannabis; discuss the importance of the 2018 and 2024 Farm Bill; explain the roll of terpenes and compare the different types of terpenes in cannabis vs. other plants; and discuss some of the pharmacological activity of terpenes in cannabis and cannabis products. 5-Strongly Agree
This activity will result in a change in my practice behavior and improve my clinical skills.	This activity will result in a change in my practice behavior and improve my clinical skills. 1-Strongly Disagree	This activity will result in a change in my practice behavior and improve my clinical skills. 2-Disagree	This activity will result in a change in my practice behavior and improve my clinical skills. 3-Neutral	This activity will result in a change in my practice behavior and improve my clinical skills. 4-Agree	This activity will result in a change in my practice behavior and improve my clinical skills. 5-Strongly Agree
This activity will enhance my efficacy in managing and treating patients.	This activity will enhance my efficacy in managing and treating patients. 1-Strongly Disagree	This activity will enhance my efficacy in managing and treating patients. 2-Disagree	This activity will enhance my efficacy in managing and treating patients. 3-Neutral	This activity will enhance my efficacy in managing and treating patients. 4-Agree	This activity will enhance my efficacy in managing and treating patients. 5-Strongly Agree
This activity addressed barriers to my optimal patient management.	This activity addressed barriers to my optimal patient management. 1-Strongly Disagree	This activity addressed barriers to my optimal patient management. 2-Disagree	This activity addressed barriers to my optimal patient management. 3-Neutral	This activity addressed barriers to my optimal patient management. 4-Agree	This activity addressed barriers to my optimal patient management. 5-Strongly Agree
The speakers communicated effectively and achieved the outlined objectives.	The speakers communicated effectively and achieved the outlined objectives. 1-Strongly Disagree	The speakers communicated effectively and achieved the outlined objectives. 2-Disagree	The speakers communicated effectively and achieved the outlined objectives. 3-Neutral	The speakers communicated effectively and achieved the outlined objectives. 4-Agree	The speakers communicated effectively and achieved the outlined objectives. 5-Strongly Agree
I was adequately informed of the speakers' disclosure.	I was adequately informed of the speakers' disclosure. 1-Strongly Disagree	I was adequately informed of the speakers' disclosure. 2-Disagree	I was adequately informed of the speakers' disclosure. 3-Neutral	I was adequately informed of the speakers' disclosure. 4-Agree	I was adequately informed of the speakers' disclosure. 5-Strongly Agree
This presentation was fairly balanced and free of commercial bias.	This presentation was fairly balanced and free of commercial bias. 1-Strongly Disagree	This presentation was fairly balanced and free of commercial bias. 2-Disagree	This presentation was fairly balanced and free of commercial bias. 3-Neutral	This presentation was fairly balanced and free of commercial bias. 4-Agree	This presentation was fairly balanced and free of commercial bias. 5-Strongly Agree

Question Title

* 6. If bias was detected, what factors do you believe contributed to the bias?

Question Title

* 7. What three actions will you take or changes will you make as a result of the content delivered in this activity?

Question Title

* 8. Please list any comments you have about the speakers or the activity.

Question Title

* 9. What barriers exist that may prevent you from successfully making change in your practice?

Question Title

* 10. Please list any questions you have for the faculty about this webinar.

Question Title

* 11. Please list any unmet educational needs that TAFP can meet through future educational activities.

Question Title

* 12. Please list any general comments you have in regards to this activity (subject matter, format, faculty, technology, etc.)

Question Title

* 13. Please complete your contact information in order to receive your CME certificate. Certificates will be emailed to the email address provided below.

Full Name

Designation (MD/DO)

City

State

ZIP

Email Address

Phone Number

Thank you for participating in this enduring CME activity on medical cannabis. CME certificates will emailed to you within 10 business days of completion of the activity. Please contact TAFP at registrar@tafp.org if you have any questions about the activity or CME credit.

Exploring the Science and Myths of Medical Cannabis CME Webinar Part 1

Part 1 – The Endocannabinoid System and Hemp and Cannabis

Question Title

* 1. Which endocannabinoid receptor has a higher density in the CNS and is responsible for the psychoactive effects of THC?

Question Title

* 2. CB1 and CB2 receptors are only found in the brain.

Question Title

* 3. ⁠⁠CBD and THC are the only phytocannabinoids that have beneficial effects.

Question Title

* 4. Should cannabis be taught in medical school/residency? (Yes or No and Why?)

Question Title

* 5. Please rate how much you agree or disagree with the following statements. (1-Strongly Disagree to 5-Strongly Agree)

Question Title

* 6. If bias was detected, what factors do you believe contributed to the bias?

Question Title

* 7. What three actions will you take or changes will you make as a result of the content delivered in this activity?

Question Title

* 8. Please list any comments you have about the speakers or the activity.

Question Title

* 9. What barriers exist that may prevent you from successfully making change in your practice?

Question Title

* 10. Please list any questions you have for the faculty about this webinar.

Question Title

* 11. Please list any unmet educational needs that TAFP can meet through future educational activities.

Question Title

* 12. Please list any general comments you have in regards to this activity (subject matter, format, faculty, technology, etc.)

Question Title

* 13. Please complete your contact information in order to receive your CME certificate. Certificates will be emailed to the email address provided below.